Evidence mapPaperPMID 37017294Full record

ArticleBiomaterials science2023

Extrahepatic transplantation of 3D cultured stem cell-derived islet organoids on microporous scaffolds.

Elizabeth Bealer, Kelly Crumley, Daniel Clough, Jessica King, Maya Behrend, Connor Annulis, Feiran Li, Scott Soleimanpour, Lonnie D Shea

Open access · greenAbstract read
In one paragraph

Article in Biomaterials science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Exendin-4 enhances insulin-positive phenotype of human pluripotent stem cell-derived β cells during transplantation.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  5. Review
  6. Article
  7. Organoid scaffold materials: research and application.Frontiers in bioengineering and biotechnology · 2025
    Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Elizabeth BealerDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.ORCID http://orcid.org/0000-0001-6767-4091
Kelly CrumleyDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.ORCID http://orcid.org/0000-0002-8754-9092
Daniel CloughDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.
Jessica KingDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.ORCID http://orcid.org/0000-0002-2642-5977
Maya BehrendDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.
Connor AnnulisDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.
Feiran LiDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.
Scott SoleimanpourDepartment of Internal Medicine and Division of Metabolism, Endocrinology & Diabetes, University of Michigan, Ann Arbor, MI, USA.
Lonnie D SheaDepartment of Biomedical Engineering, University of Michigan, 1119 Carl A. Gerstacker Building, 2200 Bonisteel Boulevard, Ann Arbor, MI 48109, USA. ldshea@umich.edu.
University of Michigan · US

Funding

Pilot and Feasibility ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2022 to 2025
$4.9M
Functional interaction of transcriptional regulators in endocrine lineage specificationR01DK135032 · NIDDK · UNIVERSITY OF PENNSYLVANIA · 2024 to 2025
$1.4M
Type 2 diabetes risk variant effects on mitochondrial (patho)physiologyR01DK136671 · JACKSON LABORATORY · 2025 to 2025
$740k
Control of insulin secretion by mitochondrial fusionR01DK135268 · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2025 to 2025
$603k
BLRD VA I01 BX004444NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK108921NIDDK NIH HHS R01 DK121462NIDDK NIH HHS R01 DK135268NIDDK NIH HHS R01 DK136671NIDDK NIH HHS U01 DK127747
6 · The paper itself

Abstract

Stem cell differentiation methods have been developed to produce cells capable of insulin secretion which are showing promise in clinical trials for treatment of type-1 diabetes. Nevertheless, opportunities remain to improve cell maturation and function. Three-dimensional (3D) culture has demonstrated improved differentiation and metabolic function in organoid systems, with biomaterial scaffolds employed to direct cell assembly and facilitate cell-cell contacts. Herein, we investigate 3D culture of human stem cell-derived islet organoids, with 3D culture initiated at the pancreatic progenitor, endocrine progenitor, or immature β-cell stage. Clusters formed by reaggregation of immature β-cells could be readily seeded into the microporous poly(lactide-

Indexed as

Diabetes Mellitus, ExperimentalAnimalsCell DifferentiationHumansInsulinMiceOrganoidsStem CellsTissue ScaffoldsInsulin

Identifiers

PMID37017294
PMCPMC10192035
OpenAlexW4362513405

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.